Ed. Programs

Program Faculty

 

 

 

 

Department of Laboratory Medicine and Pathology

Clinical Laboratory Scientist (CLS)/ Medical Technolgist Program(MT)

Pre-Clinical Blood Bank Competencies

Hematology Competencies Chemistry Competencies Immunology Competencies Blood Bank Competencies Urinalysis Competencies Microbiology Competencies

The clinical rotation for Blood Bank at HCMC consists of 6 weeks (3 weeks in the first half of the internship, 3 weeks in last half) of practical laboratory experience supplemented with unknowns, clinical case studies, and self-instructional units. One additional day is spent at a Blood Center. Near the end of the clinical internship, additional case studies are presented as part of a year-end review.

Prior to the internship at HCMC, it is expected that the student will have mastered each of the items listed in the following Blood Bank Pre-clinical Competencies. These competencies consist of basic blood bank procedures and theory that are to be learned during the summer program at the university.

NOTE: Each student is required to write out answers for all of the objectives. If the objective involves the performance of some activity, describe what you did in your college courses in order to meet that objective. These answers must be turned in to the HCMC program director on the first day of orientation. They will be evaluated for completeness by the HCMC education techs.

Each student is also expected to review the Blood Bank Pre-clinical Competencies immediately prior to the first week of their internship in the Blood Bank section. Complete knowledge of these competencies will allow the student to move through the clinical rotation with greater ease and fewer additional assignments and test samples.

Bev Osekowsky, MT (ASCP)
Reviewed 1/07


BLOOD BANK PRE-CLINICAL COMPETENCIES
Upon entering the nine months of clinical study the student will be able to:

I. BASIC IMMUNOLOGY
  A. Define antigen and antibody as they pertain to blood banking.
B. List the 5 classes of immunoglobulins and note which classes are encountered in the Blood Bank.
C. Compare and contrast the different immunoglobulins. Include such considerations as basic units (number and composition), ability to cross the placenta, optimal temperature reactivity, number of binding sites and concentration in normal serum.
D. State two indications that an antigen-antibody reaction has occurred in blood bank testing.
E. Describe and be able to draw pictures of the two stages of agglutination reaction (include factors and/or conditions affecting each stage).
F. Describe and compare the characteristics of a primary response to those of a secondary response.
G. Discuss why either serum or plasma may be used in most blood bank testing.

II. TECHNIQUES
  A. Prepare a 2%-5% RBC suspension for testing.
B. Perform routine ABO/Rh typing using the tube technique.
C. Read and grade positive reactions (macroscopic and microscopic) according to their observed strength (using proper optical aids) as outlined in the AABB Technical Manual.
D. Perform direct antiglobulin tests.
E. Perform antibody screens.

III. ABO
 

A. Explain why the ABO blood group is the most important system encountered in the Blood Bank.
B. Define cell typing (forward grouping or front type).
C. Define serum typing (reverse grouping or back type).
D. Explain why ABO antibodies are found in most serums regardless of previous RBC immunization.
E. For each of the following, list the ABO testing discrepancies that would be observed and explain how to resolve each discrepancy:

  1. Reverse (serum) typing is weak or absent.
2. Patient is A2 with anti-A1.
3. A group A patient has been transfused with group O packed red blood cells.
4. Patient has acquired B phenomenon.

F. Define phenotype.
G. Define genotype.

IV. Rh
 

A. State the two currently accepted theories of inheritance in the Rh system.
B.List the 5 most common antigens which comprise the Rh system using the Wiener and Fisher-Race nomenclature. Note which antigen constitutes Rh positive or Rh negative status.
C. Describe the weak D variant and discuss testing methods for identification. (Include discussion of when such testing is necessary).
D. Discuss the significance of a positive direct antiglobulin test on cells being tested for weak D.


V. ANTIBODY DETECTION
  A. Discuss and draw a picture of the principles of the antiglobulin test.
B. Draw the steps in the direct antiglobulin test (DAT) and state two (2)applications of the DAT.
C. State two components of polyspecific antihuman globulin reagents.
D. List two monospecific antihuman globulin reagents.
E. Draw the steps in the indirect antiglobulin test (IAT) and state two (2) applications of the IAT.
F. Define allo antibody.
G. Define auto antibody.
H. Define dosage and give examples of antibodies noted to exhibit this phenomenon.
I. Using the crossing-out technique, interpret the attached antibody panel. Show your work and explain the process you followed.
J. State the purpose of an eluate.

VI. CROSSMATCHING
  A. List the main steps of the major crossmatch.
B. List acceptable ABO/Rh types (for both red cell products and plasma products) that patients can receive if that patient's type is not available.
C. Explain the significance of a compatibility test.

VII. REFERENCE

AABB Technical Manual, Current edition

RETURN TO THE TOP OF THE PAGELab Glassware